John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 20, 2024, involving the acquisition of 160 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have increased to a total of 333 shares. The transaction reflects a continued investment in the company by an individual with a remarked relationship to the issuer.

John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 20, 2024, involving the acquisition of 160 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have increased to a total of 333 shares. The transaction reflects a continued investment in the company by an individual with a remarked relationship to the issuer.